Breast cancer treatment and ovarian failure: risk factors and emerging genetic determinants (Q79227006)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17036039%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

review article

1 reference

title

Breast cancer treatment and ovarian failure: risk factors and emerging genetic determinants (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17036039%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

5

David A Flockhart

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17036039%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1

Vered Stearns

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17036039%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

2

Bryan Schneider

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17036039%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

N Lynn Henry

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17036039%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Daniel F Hayes

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17036039%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

12 October 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17036039%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

published in

Nature Reviews Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17036039%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17036039%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17036039%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

886-893

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17036039%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrc1992

20 December 2019

exact match

0 references

cites work

Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer

1 reference

The relation between survival and age at diagnosis in breast cancer.

31 March 2020

1 reference

UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years.

31 March 2020

1 reference

Effect of screening and adjuvant therapy on mortality from breast cancer

31 March 2020

1 reference

New prognostic factors for breast cancer recurrence

31 March 2020

1 reference

2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology

31 March 2020

1 reference

Tamoxifen in the treatment of breast cancer

31 March 2020

1 reference

Premature ovarian failure

31 March 2020

1 reference

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial

31 March 2020

1 reference

Quality of health care delivered to adults in the United States

31 March 2020

1 reference

A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer

31 March 2020

1 reference

A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer

31 March 2020

1 reference

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

31 March 2020

1 reference

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

31 March 2020

1 reference

Breast Cancer in Younger Women: Reproductive and Late Health Effects of Treatment

31 March 2020

1 reference

Clinical review 8: Clinical heterogeneity of involutional osteoporosis: implications for preventive therapy

31 March 2020

1 reference

Estrogen and coronary heart disease in women

31 March 2020

1 reference

Association of breast cancer and its therapy with menopause-related symptoms

31 March 2020

1 reference

Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: results from INT 0101 (E5188).

31 March 2020

1 reference

Iatrogenic acute estrogen deficiency and psychiatric syndromes in breast cancer patients.

31 March 2020

1 reference

Coping and cognitive factors in adaptation to in vitro fertilization failure.

31 March 2020

1 reference

Psychosocial distress and infertility: men and women respond differently

31 March 2020

1 reference

Web-based survey of fertility issues in young women with breast cancer.

31 March 2020

1 reference

Discussions regarding reproductive health for young women with breast cancer undergoing chemotherapy.

31 March 2020

1 reference

The fertility- and menopause-related information needs of younger women with a diagnosis of breast cancer: a qualitative study

31 March 2020

1 reference

American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.

31 March 2020

1 reference

Inadvertent use of aromatase inhibitors in patients with breast cancer with residual ovarian function: cases and lessons

31 March 2020

1 reference

Adjuvant aromatase inhibitors for early breast cancer after chemotherapy-induced amenorrhoea: caution and suggested guidelines

31 March 2020

1 reference

Risk of menopause during the first year after breast cancer diagnosis

31 March 2020

1 reference

Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study

31 March 2020

1 reference

Regulation of primordial follicle assembly and development

31 March 2020

1 reference

Molecular biology and physiological role of the oocyte factor, BMP-15.

31 March 2020

1 reference

Preservation of fertility and ovarian function and minimalization of chemotherapy associated gonadotoxicity and premature ovarian failure: the role of inhibin-A and -B as markers

31 March 2020

1 reference

Serum müllerian-inhibiting substance levels during normal menstrual cycles

31 March 2020

1 reference

Antimüllerian hormone serum levels: a putative marker for ovarian aging

31 March 2020

1 reference

Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transition

31 March 2020

1 reference

Age at natural menopause in a population-based screening cohort: the role of menarche, fecundity, and lifestyle factors

31 March 2020

1 reference

Epidemiology of the menopause

31 March 2020

1 reference

Family history as a predictor of early menopause.

31 March 2020

1 reference

Hypothalamic-pituitary-ovarian axis in women with operable breast cancer treated with adjuvant CMF and tamoxifen.

31 March 2020

1 reference

Ovarian function in patients receiving adjuvant chemotherapy for breast cancer

31 March 2020

1 reference

Pituitary-ovarian function in breast cancer patients on adjuvant chemoimmunotherapy

31 March 2020

1 reference

Cyclophosphamide-Induced Ovarian Failure

31 March 2020

1 reference

Gonadal dysfunction in patients receiving chemotherapy for cancer

31 March 2020

1 reference

Amenorrhea in patients with Hodgkin's disease treated with antineoplastic agents

31 March 2020

1 reference

Prognostic effect of amenorrhoea and elevated serum gonadotropin levels induced by adjuvant chemotherapy in premenopausal node-positive breast cancer patients

31 March 2020

1 reference

Adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with axillary node-positive breast cancer: an update of the Guy's/Manchester trial

31 March 2020

1 reference

Prognostic role of amenorrhea induced by adjuvant chemotherapy in premenopausal patients with early breast cancer

31 March 2020

1 reference

Adjuvant chemotherapy with cyclophosphamide or CMF in premenopausal women with stage II breast cancer

31 March 2020

1 reference

The magnitude of endocrine effects of adjuvant chemotherapy for premenopausal breast cancer patients. The International Breast Cancer Study Group.

31 March 2020

1 reference

Ovarian function and adjuvant chemotherapy for early breast cancer

31 March 2020

1 reference

Impact of cyclophosphamide on relationships between carboplatin exposure and response or toxicity when used in the treatment of advanced ovarian cancer

31 March 2020

1 reference

A randomized trial comparing 12 weeks versus 36 weeks of adjuvant chemotherapy in stage II breast cancer.

31 March 2020

1 reference

Adjuvant docetaxel for node-positive breast cancer

31 March 2020

1 reference

The role of genetic factors in age at natural menopause

31 March 2020

1 reference

DNA sequence variation of Homo sapiens

31 March 2020

1 reference

Identification of new variants of human BMP15 gene in a large cohort of women with premature ovarian failure.

31 March 2020

1 reference

Missense mutations in the BMP15 gene are associated with ovarian failure

31 March 2020

1 reference

A prospective study of factors affecting age at menopause.

31 March 2020

1 reference

Factors associated with age at natural menopause in a multiethnic sample of midlife women

31 March 2020

1 reference

A common polymorphism renders the luteinizing hormone receptor protein more active by improving signal peptide function and predicts adverse outcome in breast cancer patients.

31 March 2020

1 reference

Pharmacogenomics--drug disposition, drug targets, and side effects

31 March 2020

1 reference

Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritis

31 March 2020

1 reference

Identification of the polymorphically expressed CYP2C19 and the wild-type CYP2C9-ILE359 allele as low-Km catalysts of cyclophosphamide and ifosfamide activation.

31 March 2020

1 reference

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

31 March 2020

1 reference

A common genetic basis for idiosyncratic toxicity of warfarin and phenytoin.

31 March 2020

1 reference

CYP2C9 Ile359 and Leu359 variants: enzyme kinetic study with seven substrates

31 March 2020

1 reference

Comparative studies on the catalytic roles of cytochrome P450 2C9 and its Cys- and Leu-variants in the oxidation of warfarin, flurbiprofen, and diclofenac by human liver microsomes

31 March 2020

1 reference

The effect of genetic polymorphisms in CYP2C9 on sulphamethoxazole N-hydroxylation.

31 March 2020

1 reference

Catalytic activity of three variants (Ile, Leu, and Thr) at amino acid residue 359 in human CYP2C9 gene and simultaneous detection using single-strand conformation polymorphism analysis

31 March 2020

1 reference

Torsemide metabolism by CYP2C9 variants and other human CYP2C subfamily enzymes

31 March 2020

1 reference

Pharmacokinetics of chlorpheniramine, phenytoin, glipizide and nifedipine in an individual homozygous for the CYP2C9*3 allele

31 March 2020

1 reference

Genetic association between sensitivity to warfarin and expression of CYP2C9*3

31 March 2020

1 reference

Phenotypic and genotypic investigations of a healthy volunteer deficient in the conversion of losartan to its active metabolite E-3174

31 March 2020

1 reference

Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data.

31 March 2020

1 reference

Clinical significance of the cytochrome P450 2C19 genetic polymorphism

31 March 2020

1 reference

Isolation and characterization of human liver cytochrome P450 2C19: correlation between 2C19 and S-mephenytoin 4'-hydroxylation

31 March 2020

1 reference

Evidence that CYP2C19 is the major (S)-mephenytoin 4'-hydroxylase in humans

31 March 2020

1 reference

Potential options for preservation of fertility in women

31 March 2020

1 reference

American Society of Clinical Oncology recommendations on fertility preservation in cancer patients

31 March 2020

1 reference

Goserelin as ovarian protection in the adjuvant treatment of premenopausal breast cancer: a phase II pilot study.

31 March 2020

1 reference

HABITS (hormonal replacement therapy after breast cancer--is it safe?), a randomised comparison: trial stopped

31 March 2020

1 reference

Menopause and breast cancer: addressing the secondary health effects of adjuvant chemotherapy.

31 March 2020

1 reference

31 March 2020

1 reference

Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation

31 March 2020

1 reference

Primary care for survivors of breast cancer

31 March 2020

1 reference

Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane

31 March 2020

1 reference

Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes

31 March 2020

1 reference

Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer

31 March 2020

1 reference